An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Treatment Gaining Popularity Online
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Voice Concerns
However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.
Some professionals said the demand for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the British medical regulations.
Some content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.
Service Reaction and Material Elimination
Based on TikTok, the platform has removed problematic material and prohibited associated hashtags and query recommendations. The organization stated it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Investigations also discovered groups with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of users, populated with images of weight loss, positive reviews and detailed instructions for mixing or administering at residence.
Within minutes of joining one group, a seller posted contact information, where the majority of transactions occur. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.
Product Details and Costs
Inside these groups, posts display dark colored parcels with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service said it regularly moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has previously seen individuals harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to potentially serious health risks”.
